Tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma.
about
Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantationIncorporation of high-dose 131I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 studyEfficacy of tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma: the Korean Society of Pediatric Hematology-Oncology experience over 6 years (2000-2005).Efficacy of high-dose chemotherapy and autologous stem cell transplantation in patients with relapsed medulloblastoma: a report on the Korean Society for Pediatric Neuro-Oncology (KSPNO)-S-053 studyReduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuroectodermal tumorStriking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era.Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system.Clinical Significance of Persistent Tumor in Bone Marrow during Treatment of High-risk Neuroblastoma.Hematologic recovery after tandem high-dose chemotherapy and autologous stem cell transplantation in children with high-risk solid tumors.Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk or Recurrent Bone and Soft Tissue SarcomasNeuroblastoma originating from extra-abdominal sites: association with favorable clinical and biological features.High-dose chemotherapy and autologous stem cell rescue in patients with high-risk stage 3 neuroblastoma: 10-year experience at a single center.Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.The degree of tumor volume reduction during the early phase of induction chemotherapy is an independent prognostic factor in patients with high-risk neuroblastoma.Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.A single center clinical analysis of children with neuroblastoma.Treatment of high-risk neuroblastoma.Autologous cord blood transplantation in a child with stage 4 neuroblastoma.Toxicity of tandem high-dose chemotherapy and autologous stem cell transplantation using carboplatin-thiotepa-etoposide and cyclophosphamide-melphalan regimens for malignant brain tumors in children and young adults.Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma.Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma.Tandem High-dose Chemotherapy and Autologous Stem Cell Transplantation in Children with Brain Tumors : Review of Single Center Experience.
P2860
Q24186451-49B8066B-18F9-407D-9B1D-CE1645B9AE4BQ33691441-948C2BBE-A2D9-4393-836B-7912D6CA47FAQ33807214-989CDC02-9AFC-4355-92A1-E0ED9F66BCEBQ34014748-FAB8FB2B-FB88-45AD-B1BC-748E991B9FD3Q34316845-95378A2F-274F-4F4F-AAD9-47DC220C7B44Q35077703-632C1069-3005-41F7-B994-5C403F31C382Q35730809-577FFA62-62EB-4742-B0C4-657370B0AF51Q35905092-9DCAA9C3-035A-4A3B-A5A9-E8BDDDCD92A0Q36589477-E785DDA6-7606-4DE4-9D7B-4DBB36AE15F5Q36627160-3D76E9CC-1DFD-40F4-9210-7E01226F14EFQ36989758-106AAF10-9D7B-4FC8-BAA3-D50A53D66C77Q37232057-1F660263-AD33-40E5-82F0-06E46EB7B391Q37284671-6086DEEE-3DBD-4CDB-8B88-1800B600329AQ38014527-BF09635F-3807-4287-A8BB-307BA77FE5BFQ38041019-DCF6192B-6F57-41FD-B178-3DED832A7654Q38458733-EF258D13-1753-45D0-AEF5-34BE3EFCA56BQ38608663-6E1CBB0E-865A-424B-8C9E-C379B3B37456Q40257611-D7072525-C48A-484A-8BA3-7284FCAF4E6EQ41761113-470CB602-2D3C-499C-B706-F90A23DEA2D0Q44395625-8562B18D-9BF4-480E-B163-301D6A2066FCQ48612986-1BA7B21C-8CB5-4E04-B135-D0F45BE0ADA0Q51768675-45592B40-16EE-479F-8B75-14DDB5FD09F3Q53324000-D40079C4-DD9E-416D-9554-3306551D2321Q55127179-C0BC8EA2-6294-4DF7-B0CA-F7A6AE0C670DQ55531791-1B1A21B1-3F96-4C75-A881-6D2E24C631C9
P2860
Tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Tandem high-dose chemotherapy ...... ge with stage 4 neuroblastoma.
@en
Tandem high-dose chemotherapy ...... ge with stage 4 neuroblastoma.
@nl
type
label
Tandem high-dose chemotherapy ...... ge with stage 4 neuroblastoma.
@en
Tandem high-dose chemotherapy ...... ge with stage 4 neuroblastoma.
@nl
prefLabel
Tandem high-dose chemotherapy ...... ge with stage 4 neuroblastoma.
@en
Tandem high-dose chemotherapy ...... ge with stage 4 neuroblastoma.
@nl
P2093
P356
P1476
Tandem high-dose chemotherapy ...... ge with stage 4 neuroblastoma.
@en
P2093
P2860
P2888
P356
10.1038/SJ.BMT.1705691
P407
P577
2007-04-30T00:00:00Z